-$1.38 EPS Expected for Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) This Quarter

Brokerages expect Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Rating) to announce earnings per share (EPS) of ($1.38) for the current fiscal quarter, according to Zacks Investment Research. Six analysts have made estimates for Enanta Pharmaceuticals’ earnings. The lowest EPS estimate is ($1.75) and the highest is ($0.82). Enanta Pharmaceuticals posted earnings of ($1.19) per share […]

Related Keywords

Canada ,Bruce La Carter , ,Morgan Stanley ,Zacks Investment Research ,Enanta Pharmaceuticals Company Profile Get Rating ,Nasdaq ,First Trust Advisors ,Wells Fargo Company ,Enanta Pharmaceuticals Inc ,Enanta Pharmaceuticals ,Abbott Laboratories ,Royal Bank ,Get Rating ,Zacks Investment ,Enanta Pharmaceutical ,Director Bruce ,Trust Advisors ,Pharmaceuticals Company Profile ,Nasdaq Enta ,Enta ,Medical ,Ratings ,Consensus ,